LivaNova PLC (LIVN) stock
LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3032% above fair value
$94.54+2.62 (+2.85%)
Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –
LivaNova gross margin
Gross margin is gross profit as a percentage of revenue.
LivaNova's gross margin for the twelve months ending Jun 30, 2026 was 68.1%. For fiscal 2025 it was 67.7%, against 68.1% the year before. The highest annual figure on record is 91.4% in fiscal 2013.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 67.7% | −0.4 |
| FY2024 | Dec 31, 2024 | 68.1% | +2.6 |
| FY2023 | Dec 31, 2023 | 65.5% | −3.7 |
| FY2022 | Dec 31, 2022 | 69.2% | +1.0 |
| FY2021 | Dec 31, 2021 | 68.2% | +4.5 |
| FY2020 | Dec 31, 2020 | 63.7% | −3.1 |
| FY2019 | Dec 31, 2019 | 66.8% | −0.6 |
| FY2018 | Dec 31, 2018 | 67.4% | +3.0 |
| FY2017 | Dec 31, 2017 | 64.4% | −26.3 |
| FY2015 | Apr 24, 2015 | 90.6% | +0.3 |
| FY2014 | Apr 25, 2014 | 90.3% | −1.1 |
| FY2013 | Apr 26, 2013 | 91.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | 70.1% | +2.3 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 67.3% | −1.0 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 66.4% | −0.2 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 68.4% | −1.0 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 67.8% | +0.3 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | 68.3% | −0.7 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 66.6% | +10.3 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 69.5% | −1.1 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 67.4% | −2.4 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 68.9% | +2.8 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | 56.3% | −10.4 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | 70.5% | +2.9 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | 69.8% | −2.7 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | 66.1% | −4.0 |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | 66.8% | −7.9 |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | 67.7% | +1.1 |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | 72.5% | +7.4 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | 70.1% | +4.1 |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | 74.7% | +12.7 |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | 66.6% | +5.1 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | 65.1% | +2.0 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | 66.0% | −2.2 |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | 61.9% | −9.2 |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | 61.5% | −5.3 |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | 63.1% | −8.0 |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | 68.2% | +3.0 |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | 71.2% | +2.4 |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | 66.8% | +2.7 |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | 71.1% | +3.7 |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | 65.2% | +0.5 |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | 68.7% | +6.8 |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | 64.1% | −0.3 |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | 67.5% | +1.0 |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | 64.7% | −0.4 |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | 61.9% | −27.9 |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | 64.4% | −26.5 |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | 66.5% | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | 65.1% | – |
| Q4 FY2015CQ1 2015 | Apr 24, 2015 | 89.7% | – |
| Q3 FY2015CQ4 2014 | Jan 23, 2015 | 90.9% | – |
See a number that looks wrong?